Study guide

8.1 Chronic Pruritus, Chronic Prurigo, Dermatoses of Pregnancy & Geriatric Dermatology

UEMS European Board of Dermatovenereology Diploma Examination Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Structure, Eligibility & Examination Regulations

1.1 EBDVD Exam Format, Session Timing & Scoring Rules 1.2 Eligibility Routes, Application Requirements & Re-take Regulations 1.3 UEMS-EBDV Governance, European Training Requirements & Diploma Recognition

2 Chapter 2: Dermatologic Terminology, Lesion Morphology & Skin Biology

2.1 Skin Anatomy, Epidermal Biology & Barrier Function 2.2 Primary & Secondary Lesion Morphology 2.3 Cutaneous Immunology & Pathophysiological Reaction Patterns

3 Chapter 3: Dermatopathology & Diagnostic Procedures

3.1 Biopsy Selection, Processing & Special Staining Techniques 3.2 Major Histopathologic Patterns & Tissue Reaction Types 3.3 Direct & Indirect Immunofluorescence Microscopy

4 Chapter 4: Epidemiology, Photobiology & Occupational Dermatology

4.1 Epidemiological Principles & Cutaneous Disease Burden 4.2 Photobiology & Photoprotection 4.3 Occupational Dermatoses & Contact Sensitisation Surveillance

5 Chapter 5: Papulosquamous, Follicular & Adnexal Disease

5.1 Psoriasis: Variants, Psoriatic Arthritis, Comorbidity & European Management 5.2 Lichen Planus, Lichenoid Eruptions & Other Papulosquamous Disorders 5.3 Acne Vulgaris, Rosacea & Perioral Dermatitis 5.4 Hidradenitis Suppurativa, Hyperhidrosis & Other Sweat Gland Disorders

6 Chapter 6: Hair, Nails & Pigmentary Disorders

6.1 Hair Disorders: Non-Scarring & Scarring Alopecia, Hair Shaft Defects & Hirsutism 6.2 Nail Disorders, Onychomycosis & Nail Unit Tumours 6.3 Pigmentary Disorders: Vitiligo, Melasma & Other Hypo- and Hyperpigmentation

7 Chapter 7: Drug Reactions, Granulomatous & Deposition Disease and Skin Signs of Systemic Disease

7.1 Cutaneous Adverse Drug Reactions, SCARs & Dermatological Emergencies 7.2 Granulomatous & Deposition Disorders and Panniculitis 7.3 Skin Signs of Systemic Disease, Porphyrias, Nutritional Deficiency & Paraneoplastic Dermatoses

8 Chapter 8: Pruritus, Pregnancy & Geriatric Dermatology, Physical Injury and Mucosal Disease

8.1 Chronic Pruritus, Chronic Prurigo, Dermatoses of Pregnancy & Geriatric Dermatology 8.2 Burns, Cold, Heat & Radiation Injury and the Principles of Wound Healing 8.3 Oral Mucosal, Lip, Genital Mucosal & Perianal (Proctological) Disease

9 Chapter 9: Autoimmune Bullous Diseases

9.1 Pemphigus Group: Pemphigus Vulgaris, Foliaceus & Paraneoplastic Pemphigus 9.2 Pemphigoid Group & Epidermolysis Bullosa Acquisita 9.3 Dermatitis Herpetiformis & Linear IgA Bullous Dermatosis

10 Chapter 10: Eczematous Disorders, Urticaria & Allergology

10.1 Atopic Dermatitis: Pathogenesis, Phenotypes & European Management 10.2 Allergic & Irritant Contact Dermatitis: Pathogenesis, Investigation & Common Allergens 10.3 Urticaria, Angioedema & Cutaneous Mastocytosis 10.4 Immediate-Type Allergy: Diagnostics, Anaphylaxis, Food, Venom & Drug Allergy

11 Chapter 11: Connective Tissue Diseases & Cutaneous Vasculitis

11.1 Cutaneous Lupus Erythematosus Spectrum & Systemic Manifestations 11.2 Dermatomyositis, Systemic Sclerosis & Scleroderma Spectrum 11.3 Cutaneous Vasculitis & Neutrophilic Dermatoses

12 Chapter 12: Paediatric & Genetic Dermatology

12.1 Vascular Anomalies & Benign Neonatal Dermatoses 12.2 Hereditary Ichthyoses & Disorders of Keratinisation 12.3 Genodermatoses, Neurocutaneous Syndromes & Epidermolysis Bullosa

13 Chapter 13: Bacterial, Mycobacterial, Parasitic & Zoonotic Cutaneous Infections

13.1 Bacterial Skin & Soft Tissue Infections 13.2 Mycobacterial Infections: Cutaneous Tuberculosis, Leprosy & Atypical Mycobacteria 13.3 Parasitic Infestations, Arthropod Bites & Cutaneous Leishmaniasis 13.4 Lyme Borreliosis, Rickettsioses & Other Zoonotic and Travel-Related Skin Infections

14 Chapter 14: Viral & Fungal Cutaneous Infections

14.1 Herpesviridae Infections: HSV, VZV & HHV-8 14.2 Poxviruses & Human Papillomavirus Manifestations 14.3 Superficial, Subcutaneous & Deep Mycoses

15 Chapter 15: Sexually Transmitted Infections & Genital Infections

15.1 Syphilis: Pathogenesis, Clinical Stages, Serology & European Management 15.2 Neisseria gonorrhoeae, Chlamydia trachomatis & Genital Ulcer Diseases 15.3 HIV-Related Dermatoses, Partner Notification & Anogenital Lichen Sclerosus 15.4 Non-Gonococcal Urethritis, Mycoplasma genitalium, Trichomoniasis, Vaginal Infections & Balanitis

16 Chapter 16: Sexual Health Services, HIV Prevention & Anogenital Medicine

16.1 STI Epidemiology, Prevention, Services, Sexual History, HIV Testing, ART & PrEP/PEP 16.2 HPV-Related Anogenital Neoplasia, Cervical Screening & Common Gynaecological and Andrological Disorders 16.3 STIs in Pregnancy, Neonates & Children, Contraception, Sexual Health & Psychosexual Problems

17 Chapter 17: Keratinocyte Carcinomas, Precancerous Lesions & Other Skin Tumours

17.1 Actinic Keratoses, Bowen Disease & Field Cancerisation 17.2 Basal Cell Carcinoma: Subtypes, Risk Stratification & Management 17.3 Cutaneous Squamous Cell Carcinoma & Keratoacanthoma 17.4 Benign & Malignant Epidermal, Adnexal, Mesenchymal and Vascular Tumours, Cysts, Histiocytoses & Metastases

18 Chapter 18: Melanocytic Naevi & Melanoma

18.1 Benign Melanocytic Naevi: Acquired, Congenital, Spitz, Blue, Halo & Atypical Naevi 18.2 Melanoma Risk Factors, Clinical Presentation & Biopsy Protocol 18.3 Melanoma Histopathology, Breslow Thickness & Staging 18.4 Systemic Therapy for Advanced & Metastatic Melanoma

19 Chapter 19: Dermoscopy, Skin Imaging & Cutaneous Lymphomas

19.1 Dermoscopic Principles, Structures & Algorithmic Approaches 19.2 Dermoscopy of Non-Melanocytic Cutaneous Neoplasms 19.3 Non-Invasive Skin Imaging, Skin Function Measurement, Teledermatology & Skin Cancer Surveillance 19.4 Cutaneous Lymphomas, Merkel Cell Carcinoma & Cutaneous Sarcomas

20 Chapter 20: Dermatopharmacology, Systemic Therapeutics & Prescribing

20.1 Topical Corticosteroids, Calcineurin Inhibitors & Retinoids 20.2 Systemic Immunosuppressive & Biologic Therapies 20.3 Oral Retinoids & Phototherapy Modalities 20.4 Dermatological Prescribing: Anti-Infectives, Antihistamines, Antimalarials, Dapsone, Special Populations & Cutaneous Toxicity of Cancer Therapy

21 Chapter 21: Dermatosurgery, Cryotherapy, Lasers & Aesthetic Procedures

21.1 Surgical Anatomy, Local Anaesthesia & Excision Principles 21.2 Cutaneous Reconstructive Flaps, Skin Grafts & Surgical Complications 21.3 Cryosurgery, Electrosurgery & Cutaneous Lasers 21.4 Aesthetic & Corrective Dermatology, Photodynamic Therapy & Dermatological Radiotherapy

22 Chapter 22: Phlebology, Angiology, Psychodermatology & EBDVD Revision

22.1 Phlebology, Chronic Venous Insufficiency & Lower Extremity Ulcers 22.2 Angiology: Arterial Disease, Raynaud Phenomenon, Livedo, Thrombosis, Lymphoedema & Lipoedema 22.3 Psychodermatology, Delusional Infestation & Factitious Disorders 22.4 EBDVD Revision Strategy & Cross-Topic Review

8.1 Chronic Pruritus, Chronic Prurigo, Dermatoses of Pregnancy & Geriatric Dermatology

Key Takeaways Explain This Topic AI

Chronic pruritus is itch lasting 6 weeks or longer, and itch without a primary rash needs screening for systemic causes including kidney, liver, thyroid, iron, blood, and malignant disease.

Pemphigoid gestationis involves the umbilicus, shows linear C3 along the basement membrane on direct immunofluorescence, and is associated with prematurity and small-for-gestational-age babies.

Polymorphic eruption of pregnancy usually starts in the abdominal striae in the third trimester of a first pregnancy, spares the umbilicus, and carries no fetal risk.

Intrahepatic cholestasis of pregnancy causes itch without a primary rash, starting on the palms and soles, with raised serum bile acids; stillbirth risk rises markedly at bile acids of 100 micromol/L or more.

Dupilumab is approved in the EU for moderate-to-severe prurigo nodularis in adults who are candidates for systemic therapy.

Last updated: September 2026

  • 8.1 Chronic Pruritus, Chronic Prurigo, Dermatoses of Pregnancy & Geriatric Dermatology
  • Chronic Pruritus

Chronic pruritus is itch lasting 6 weeks or longer . The International Forum for the Study of Itch (IFSI) groups patients clinically as:

  • itch on inflamed skin (eczema, psoriasis, scabies, urticaria);
  • itch on non-inflamed skin (no primary lesions);

itch with chronic scratch lesions (excoriations, lichenification, prurigo nodules).

Causes are then classed as dermatological, systemic, neurological, psychogenic, mixed, or other .

Systemic Causes of Itch Without a Rash

  • System Examples and Clues
  • Kidney Chronic kidney disease-associated pruritus, worse in dialysis patients

Liver Cholestasis (primary biliary cholangitis, primary sclerosing cholangitis, drugs, pregnancy); itch often starts on palms and soles

Blood Iron deficiency ; polycythaemia vera ( aquagenic pruritus after bathing, JAK2 V617F); Hodgkin lymphoma (itch with night sweats and weight loss)

  • Endocrine Hyper- and hypothyroidism, diabetes
  • Infection HIV, hepatitis C, parasites
  • Drugs Opioids, hydroxyethyl starch, chloroquine (common in African patients), and many others

Neurological Brachioradial pruritus (outer forearms, linked to sun and cervical spine disease); notalgia paraesthetica (patch below the shoulder blade, T2–T6); post-herpetic itch; multiple sclerosis

Psychogenic Diagnosis of exclusion; linked to anxiety and depression

Baseline tests for itch without a rash: full blood count with differential, ferritin, kidney and liver function, thyroid function, glucose or HbA1c, and HIV and hepatitis serology when there are risk factors. Consider a chest radiograph and age-appropriate cancer screening, especially in older adults.

Stepwise European Treatment (EDF/EADV chronic pruritus guideline)

Step Measures

General Emollients, lukewarm short showers, loose cotton clothing, short nails, breaking the itch-scratch cycle, treat the cause

Topical Cooling agents (menthol, polidocanol), short courses of topical corticosteroids, calcineurin inhibitors, capsaicin (localised neuropathic itch)

Systemic by mechanism Non-sedating antihistamines (mainly for histamine-driven itch such as urticaria); gabapentin or pregabalin (neuropathic, uraemic); mirtazapine or SSRIs (paraneoplastic, psychogenic, nocturnal); naltrexone (cholestatic); rifampicin and bile acid sequestrants (cholestatic); difelikefalin (haemodialysis patients)

Phototherapy Narrowband UVB, useful in uraemic itch and chronic prurigo

Biologics Dupilumab (EU-approved for prurigo nodularis); nemolizumab (anti-IL-31 receptor A) has been approved for prurigo nodularis in the EU

Chronic Prurigo

Chronic prurigo (CPG) is defined by chronic itch (6 weeks or longer), signs of repeated scratching, and multiple pruriginous lesions (papules, nodules, or plaques). Prurigo nodularis is the nodular form, with symmetric, very itchy hyperkeratotic nodules on the extensor limbs and trunk, sparing the mid-back ("butterfly sign"). It is linked to atopy, chronic kidney and liver disease, HIV, and psychological disease. Treatment follows the itch ladder above, with potent or intralesional steroids, phototherapy, and dupilumab for moderate-to-severe disease.

Specific Dermatoses of Pregnancy

Condition Timing Clinical Features Investigations Fetal Risk Management

Atopic eruption of pregnancy Often before the 3rd trimester Eczematous or prurigo lesions in atopic women; the most common pregnancy dermatosis Sometimes raised IgE None Emollients, topical steroids, antihistamines

Polymorphic eruption of pregnancy (PEP) 3rd trimester or just after delivery; usually first pregnancy ; more common in multiple pregnancy Urticarial papules starting in abdominal striae, sparing the umbilicus DIF negative None Topical steroids, antihistamines

Pemphigoid gestationis 2nd or 3rd trimester, or after delivery Urticarial plaques around and on the umbilicus , then tense blisters Linear C3 (± IgG) along the BMZ on DIF ; anti-BP180 NC16A antibodies Prematurity, small for gestational age , mild transient neonatal blisters Potent topical steroids, systemic prednisolone; recurs earlier in later pregnancies and with hormonal contraception

Intrahepatic cholestasis of pregnancy (ICP) Usually 3rd trimester Itch without a primary rash , starting on palms and soles , then generalised; excoriations; sometimes jaundice Raised serum bile acids Preterm birth, meconium, and stillbirth ; stillbirth risk rises sharply with bile acids ≥ 100 µmol/L Ursodeoxycholic acid for symptoms; obstetric monitoring and planned delivery timing

Pustular psoriasis of pregnancy (impetigo herpetiformis) Usually 3rd trimester Generalised pustular psoriasis with fever Hypocalcaemia possible Placental insufficiency Systemic corticosteroids, ciclosporin; urgent obstetric care

Pemphigoid gestationis is linked to HLA-DR3 and DR4 and, rarely, to trophoblastic tumours. Physiological skin changes in pregnancy include melasma, linea nigra , striae gravidarum, spider naevi, palmar erythema, gum hypertrophy, and telogen effluvium after delivery.

Geriatric Dermatology

Older people have more skin disease and more complications from treatment.

Ageing skin: intrinsic ageing (thinning, loss of elasticity) combined with photoageing (wrinkles, solar elastosis, lentigines, actinic keratoses).

Xerosis and asteatotic eczema (eczéma craquelé): cracked "crazy-paving" skin on the shins, worse in winter. Treat with regular emollients and mild topical steroids.

Itch in older adults: often from xerosis, but always consider drugs, systemic disease, scabies (including crusted scabies in care homes ), and bullous pemphigoid in its non-bullous phase.

Skin tears: traumatic wounds in fragile skin; the ISTAP classification grades them by flap loss (type 1 no loss, type 2 partial, type 3 total). Replace the flap and avoid adhesive dressings.

Pressure ulcers: graded by the European and US pressure injury panels as stage 1 (non-blanchable redness of intact skin), stage 2 (partial-thickness loss), stage 3 (full-thickness skin loss, fat visible), stage 4 (exposed bone, tendon, or muscle), plus unstageable (base covered by slough or eschar) and deep tissue injury . Prevention relies on repositioning, pressure-relieving surfaces, nutrition, and moisture control.

Incontinence-associated dermatitis: irritant dermatitis from urine and faeces; protect with barrier products.

Actinic purpura and dermatoporosis: fragile, easily bruised, atrophic forearm skin.

Treatment choices: account for polypharmacy, kidney function, fall risk with sedating antihistamines, dexterity for topical treatment, and whether a patient can travel to phototherapy. Recombinant herpes zoster vaccine is recommended from 50 years in many European countries.